Gut-skin axis: Kaneka Probiotics receives Canadian market authorization for probiotic

25 Apr 2024 — Health Canada’s Natural and Non-prescription Health Products Directorate (NNHPD) authorizes Kaneka Probiotics and AB-Biotics to sell the Latilactobacillus sakei (L. sakei proBio65) probiotic in Canada, promoting a favorable gut flora that aids gut and skin health. 

The product license affirms the probiotic strain can modulate the gut-skin axis, helping to alleviate mild eczema and atopic dermatitis (AD) symptoms. The authorization covers use by kids and adolescents (aged three to 18), with a suggested daily dosage of 10 billion heat-treated probiotic organisms in a powder format for oral delivery.